[Webcast]: Addressing Disparities in Ovarian Cancer Care

Expert insights on the factors that hamper ovarian cancer health equity in the US [Real-world Strategies for Overcoming Racial Disparities in Ovarian Cancer Care]( Activity Type: Online Activity Release Date: April 23, 2021 Expiration Date: April 23, 2022 Total Price: Free Continuing Education Credits: 1.0 CME/CE for Physicians (ACCME) 1.0 CME/CE for Physician Assistants (AAPA) 1.0 CH/CE for Nurse Practitioners (AANP) 1.0 CPE for Pharmacists (ACPE + NABP) 1.0 CNE for Nurses (ANCC) 1.0 CE for Case Managers (CCM, pre-approved) Estimated Duration: 1 hour Content Last Reviewed: April 23, 2021 [Earn CME Credits]( Activity Overview: Intended Audience: Interprofessional team (Nurses, PAs, NPs, Physicians, Pharmacists, Case Managers/Navigators) specializing in gynecologic oncology Even with improved treatment options in ovarian cancer, ensuring equitable, quality care for all patients remains a significant hurdle for oncology care teams due to persistent barriers. Learn from expert faulty in this webcast as they share real-word insights and lessons learned from an ovarian cancer quality initiative conducted within three large oncology health systems. Discussion will focus on: - Aligning care with evidence-based guidelines and new clinical data - Coordinating individualized treatment plans based on clinical and molecular disease features - Implementing team-based strategies to address disparities in ovarian cancer care Expert Faculty: Kathleen N Moore, MD Course Director and Speaker Associate Professor, Section of Gynecologic Oncology Jim and Christy Everest Endowed Chair in Cancer Research Director, Oklahoma TSET Phase I Program OU Stephenson Cancer Center Oklahoma University College of Medicine Oklahoma City, OK Beth Y Karlan, MD Speaker Vice Chair, Women’s Health Research Director, Cancer Population Genetics UCLA David Geffen School of Medicine University of California, Los Angeles Los Angeles, CA Ryan J Atkinson, PharmD, MBA Moderator Senior Director of Specialty Pharmacy Strategy Maxor National Pharmacy Services, LLC Indianapolis, IN Kristi Kay Orbaugh, RN, MSN, RNP, AOCN Planner Adult Nurse Practitioner Community Hospital Oncology Physicians Indianapolis, IN Abimbola Farinde, PhD, PharmD Planner Professor of Health Care Administration Columbia Southern University College of Business Orange Beach, AL Mark A Rubin, MD Peer Reviewer Medical Director Humana Fort Lauderdale, FL Agenda: - Real-World Practice Patterns and Evidence of Disparities in Ovarian Cancer Care: Data From a Systems-Based QI Program - Factors that Hamper Ovarian Cancer Health Equity in the US - Case-Based Focus on Evidence-Based and Guideline-Aligned Care for Patients with Ovarian Cancer - New and Emerging Safety and Efficacy Data for Novel Treatment Options - Strategies for Providing Patient-Centered and Equitable Care for Patients with Ovarian Cancer Learning Objectives: - Distinguish factors that may contribute to disparities in ovarian cancer treatment and outcomes - Evaluate efficacy and safety data of new and emerging maintenance treatment regimens for patients with newly diagnosed ovarian cancer - Align biomarker testing and treatment decision-making to evidence-based guidelines CE Details & Instructions: Joint Accreditation Statement In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. Interprofessional Teams This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change. Physician Credit Designation Statement PRIME® designates this Enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Physician Assistant Accreditation Statement PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation. Nurse Practitioner Accreditation Statement PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.0 contact hour (which includes 0.34 hour of pharmacology). Pharmacist Accreditation Statement This Application-based activity has been approved for 1.0 contact hour (0.1 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-21-046-H01-P . Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity by providing your NABP ID & DOB, which must be submitted within 60 days of completion. Pharmacists with questions can contact NABP customer service (help@nabp.pharmacy). Application-based are primarily constructed to apply the information learned in the time frame allotted. Information is based on evidence as accepted in the literature by the healthcare professionals. The minimum amount of credit for these activities is 60 minutes of 1.0 contact hour. Nurse Accreditation Statement PRIME® designates this activity for 1.0 contact hour. Case Manager Accreditation Statement The Commission for Case Manager Certification designates this educational activity for 1.0 contact hour for certified case managers. Credits for this program are pre-approved. Obtaining CE Credit: - Complete the pre-activity evaluation - Complete the activity in its entirety - Complete a post-activity evaluation - Download and/or print a certificate of completion and/or submit CE credits electronically Device Requirements: - Computer, smartphone, tablet, or mobile device with audio capabilities and Internet connectivity Faculty Disclosures: *PRIME® has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The following individuals have identified relevant financial relationships with commercial interests to disclose: - Kathleen N Moore, MD (Course Director, Speaker) Advisory Board or Panel - AbbVie, Alkemeres, Aravive, AstraZeneca, Eisai, Genentech/Roche, GlaxoSmithKline/Tesaro, Immunogen, Merck, Mersana, Myriad, Tarveda, Teneo Bio, VBL Therapeutics, Vavotar Consultant - AstraZeneca - Beth Y Karlan, MD (Speaker) Advisory Board/Panel - Genentech/Roche Holding AG, Grail, Merck, Mercy BioAnalytics, Teneo Bio - Kristi Kay Orbaugh, RN, MSN, RNP, AOCN (Planner) Speakers Bureau or other Promotional Education - Astellas, AstraZeneca, Bristol-Myers Squibb, Coherus, DSI, Dova, Eli Lilly and Company, Gilead Sciences, Morphosys, Pfizer The following individuals have no relevant financial relationships with commercial interests to disclose: - Ryan J Atkinson, PharmD, MBA (Moderator) - Mark A Rubin, MD (Reviewer) - Abimbola Farinde, PhD, PharmD (Planner) All PRIME® staff participating in planning and content development have no relevant financial relationships with commercial interests to disclose. Funding Disclosure: This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by educational grants from AstraZeneca, GlaxoSmithKline and Merck & Co. Inc. Accessibility Statement: At PRIME, we are committed to ensuring that individuals with disabilities can access all of the content offered by PRIME through our website and other properties. If you are having trouble accessing primeinc.org, please email legal@ziffdavis.com for assistance. Please put "ADA Inquiry" in the subject line of your email. [Earn CME Credits]( [A Property of Everyday Health group] © 2022 Everyday Health Media, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=CME_CME_Master) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014